Solana Company Files Application to Cease to Be a Reporting Issuer in Canada

Core Viewpoint - Solana Company has applied to cease being a reporting issuer in multiple Canadian jurisdictions, which will relieve it from filing financial statements and continuous disclosure documents in Canada while continuing to comply with U.S. securities laws [1][2]. Company Overview - Solana Company (NASDAQ: HSDT) is a leading neurotech firm focused on addressing neurologic deficits through an orally applied technology platform that enhances the brain's physiological compensatory mechanisms and promotes neuroplasticity [5]. - The company also operates a digital asset treasury (DAT) aimed at acquiring and holding Solana (SOL), with the goal of maximizing SOL per share through strategic capital market use and on-chain opportunities [5]. Regulatory Actions - The company has requested an order from the British Columbia and Ontario Securities Commissions to stop being a reporting issuer in Canada, which would eliminate the requirement for financial disclosures in those jurisdictions [1][2]. - If granted, the company will continue to file necessary financial statements under U.S. securities law and Nasdaq rules [2].